Lymphazurin

Lymphazurin is a brand name of isosulfan blue, approved by the FDA in the following formulation(s):

LYMPHAZURIN (isosulfan blue - injectable; injection)

• 
  Manufacturer: COVIDIEN
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 1% ^[RLD][AP]

Has a generic version of Lymphazurin been approved?

Yes. The following products are equivalent to Lymphazurin:

isosulfan blue injectable; injection

• 
  Manufacturer: SYNERX
  
  Approval date: July 20, 2010
  
  Strength(s): 1% ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lymphazurin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Lymphazurin.

See also...

• Lymphazurin Advanced Consumer Information (Micromedex)
• Lymphazurin 1% Advanced Consumer Information (Micromedex)
• Isosulfan blue Subcutaneous Advanced Consumer Information (Micromedex)